Latest News and Press Releases

Vancouver, Sept. 05, 2023 (GLOBE NEWSWIRE) -- The global bacteriophage market, which amounted to USD 43.52 million in 2022, is poised for steady growth with a projected revenue compound annual...

Dublin, Nov. 28, 2022 (GLOBE NEWSWIRE) -- The "Bacteriophage Therapy Market: Distribution by Therapeutic Area, Route of Administration, and Geography: Industry Trends and Global Forecasts,...

NEWARK, Del, Nov. 08, 2022 (GLOBE NEWSWIRE) -- The global bacteriophage market was worth US$ 41.46 Mn in the year 2021 and is expected to reach US$ 62.72 Mn by the year 2031 at a CAGR of 4.2%...

Pune, May 15, 2022 (GLOBE NEWSWIRE) -- Global Bacteriophage Market research report 2022-2027 is a professional and in-depth study on the current state of the global Bacteriophage industry with a...

Dublin, July 23, 2021 (GLOBE NEWSWIRE) -- The "Bacteriophage Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026" report has been added to ResearchAndMarkets.com's...

Dublin, June 21, 2021 (GLOBE NEWSWIRE) -- The "Bacteriophage Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021...

YONKERS, NY--(Marketwired - March 30, 2017) - ContraFect Corporation (NASDAQ: CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for...

YONKERS, NY--(Marketwired - June 21, 2016) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody...

YONKERS, NY--(Marketwired - June 08, 2016) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody...

YONKERS, NY--(Marketwired - May 10, 2016) - ContraFect Corporation  (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein...